COIN vs COLL · P/E 64, rev $7.18B vs P/E 17, rev $181.9M
Coinbase Global Inc (COIN) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Coinbase Global Inc (COIN) is a financial data & stock exchanges company listed on US. It is led by Brian Armstrong.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported COIN revenue for 2025-12-31 was $7.18B. Net income was $1.26B. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. COIN currently screens at market cap $45.84B and trailing P/E 64.2.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
COIN currently screens at market cap $45.84B and trailing P/E 64.2. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the COIN and COLL stock pages for the full models.
Not investment advice.